Black Rock Inc. Xencor Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
203Shares Held
81.9MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA10.5MShares$124 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$102 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$72.3 Million4.16% of portfolio
-
State Street Corp Boston, MA3.82MShares$44.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.76MShares$44.3 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $703M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...